Other RAS inhibitors, such as angiotensin II receptor blockers (ARBs), renin inhibitors and even chymase inhibitors (CI), are now considered key drugs for the treatment of hypertensive patients with kidney disease [57]. This evidence concerns the gene REN and kidney disorder.